Innospec (Germany) Today

OCT Stock  EUR 72.50  1.00  1.36%   

Performance

Good

 
Weak
 
Strong

Odds Of Distress

Small

 
High
 
Low
Innospec is trading at 72.50 as of the 15th of February 2026. This is a 1.36 percent decrease since the beginning of the trading day. The stock's lowest day price was 72.0. Innospec has about a 26 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat good performance during the last 90 days. The performance scores are derived for the period starting the 17th of November 2025 and ending today, the 15th of February 2026. Click here to learn more.
Business Domain
Materials
Category
Basic Materials
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals worldwide. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado. INNOSPEC INC operates under Specialty Chemicals classification in Germany and is traded on Frankfurt Stock Exchange. The company has 24.78 M outstanding shares. More on Innospec

Moving together with Innospec Stock

  0.836MK MerckPairCorr
  0.814I1 Philip Morris InternPairCorr

Moving against Innospec Stock

  0.71ABL Abbott LaboratoriesPairCorr
  0.65BZG2 PT Bank CentralPairCorr
  0.37HK2C Hong Kong ExchangesPairCorr

Innospec Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Innospec's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Innospec or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO PresidentPatrick Williams
Business ConcentrationSpecialty Chemicals, Basic Materials, Materials, Chemicals, Specialty Chemicals, Basic Materials (View all Sectors)
Innospec's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Innospec's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
Innospec utilizes debt financing to potentially enhance returns on invested capital. The relationship between total debt and total assets provides valuable insight into Innospec's leverage profile, showing how much of Innospec's resources are funded through borrowing.
Liquidity
Innospec cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Innospec has accumulated 518.6 M in total debt with debt to equity ratio (D/E) of 29.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Innospec has a current ratio of 2.23, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Innospec until it has trouble settling it off, either with new capital or with free cash flow. So, Innospec's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Innospec sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Innospec to invest in growth at high rates of return. When we think about Innospec's use of debt, we should always consider it together with cash and equity.

Investments

(58.59 Million)
Innospec (OCT) is traded on Frankfurt Exchange in Germany and employs 2,450 people. Innospec is listed under Specialty Chemicals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.8 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Innospec's market, we take the total number of its shares issued and multiply it by Innospec's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Innospec classifies itself under Chemicals sector and is part of Materials industry. The entity has 24.78 M outstanding shares. Innospec has accumulated about 123.5 M in cash with 184.5 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.05.
Check Innospec Probability Of Bankruptcy
Ownership Allocation
Innospec secures a total of 24.78 Million outstanding shares. The majority of Innospec outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Innospec to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Innospec. Please pay attention to any change in the institutional holdings of Innospec as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Innospec Ownership Details

Innospec Historical Income Statement

At this time, Innospec's Interest Expense is most likely to increase significantly in the upcoming years. The Innospec's current Net Interest Income is estimated to increase to about 11.2 M, while Selling General Administrative is projected to decrease to roughly 293.4 M. View More Fundamentals

Innospec Stock Against Markets

Innospec Stock Analysis Notes

About 99.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.64. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Innospec recorded a loss per share of 0.04. The entity last dividend was issued on the 18th of November 2025. Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals worldwide. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado. INNOSPEC INC operates under Specialty Chemicals classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2000 people. To find out more about Innospec contact Patrick Williams at 303 792 5554 or learn more at https://innospec.com.

Innospec Quarterly Total Revenue

441.9 Million

Innospec Investment Alerts

Over 99.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Assessing Innospec Valuation After Analyst Upgrade And Insider Share Purchase - simplywall.st

Innospec Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.8 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Innospec's market, we take the total number of its shares issued and multiply it by Innospec's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

At this time, Innospec's Non Currrent Assets Other are most likely to increase significantly in the upcoming years. Innospec's management efficiency ratios could be used to measure how well Innospec manages its routine affairs as well as how well it operates its assets and liabilities.
Leadership effectiveness at Innospec is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Dividend Yield
0.0225
Operating Margin
0.0701
Profit Margin
(0.0007)
Forward Dividend Yield
0.0208
Beta
0.878

Technical Drivers

As of the 15th of February 2026, Innospec retains the Risk Adjusted Performance of 0.102, market risk adjusted performance of 0.3893, and Downside Deviation of 1.44. Concerning fundamental indicators, the technical analysis model lets you check existing technical drivers of Innospec, as well as the relationship between them. Please check out Innospec value at risk, expected short fall, and the relationship between the treynor ratio and downside variance to decide if Innospec is priced fairly, providing market reflects its last-minute price of 72.5 per share.

Innospec Price Movement Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Innospec Tanh Of Price Series is a hyperbolic price transformation function.

Innospec Outstanding Bonds

Innospec issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Innospec uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Innospec bonds can be classified according to their maturity, which is the date when Innospec has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Innospec Predictive Daily Indicators

Innospec intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Innospec stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Innospec Forecast Models

Innospec's time-series forecasting models are one of many Innospec's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Innospec's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Innospec without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Analysis Now

   

Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
All  Next Launch Module

Innospec Corporate Management

Elected by the shareholders, the Innospec's board of directors comprises two types of representatives: Innospec inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Innospec. The board's role is to monitor Innospec's management team and ensure that shareholders' interests are well served. Innospec's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Innospec's outside directors are responsible for providing unbiased perspectives on the board's policies.
When determining whether Innospec is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Innospec Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Innospec Stock. Highlighted below are key reports to facilitate an investment decision about Innospec Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Innospec. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more detail on how to invest in Innospec Stock please use our How to Invest in Innospec guide.
You can also try the Stocks Directory module to find actively traded stocks across global markets.
It's important to distinguish between Innospec's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Innospec should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Innospec's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.